Synthesis and topical antiinflammatory and antiallergic activities of antioxidant o-aminophenol derivatives. 1994

N Sugiyama, and F Akahoshi, and S Kuwahara, and M Kajii, and Y Sakaue, and H Yakumaru, and M Sugiura, and C Fukaya
Research Division, Green Cross Corporation, Osaka, Japan.

In order to develop novel compounds for topical use possessing antiallergic as well as antiinflammatory activities, a series of o-aminophenol derivatives bearing H1-antihistaminic structures were synthesized and their effects were investigated on lipid peroxidation in rat brain homogenates, antiinflammatory effection arachidonic acid- and 12-O-tetradecanoylphorbol-13- acetate-induced mouse ear edema and antiallergic effect on 48-h homologous passive cutaneous anaphylaxis in rats. Furthermore, the effects of these compounds on delayed-type hypersensitivity reaction in mice were examined. Several N-monosubstituted amino-4-methylphenols were found to exert potent inhibitory activities in all of these assays. Of these compounds, 4m was chosen for further development as AD0261.

UI MeSH Term Description Entries
D006968 Hypersensitivity, Delayed An increased reactivity to specific antigens mediated not by antibodies but by sensitized T CELLS. Hypersensitivity, Tuberculin-Type,Hypersensitivity, Type IV,Tuberculin-Type Hypersensitivity,Type IV Hypersensitivity,Delayed Hypersensitivity,Delayed Hypersensitivities,Hypersensitivity, Tuberculin Type,Tuberculin Type Hypersensitivity,Tuberculin-Type Hypersensitivities,Type IV Hypersensitivities
D008297 Male Males
D008813 Mice, Inbred ICR An inbred strain of mouse that is used as a general purpose research strain, for therapeutic drug testing, and for the genetic analysis of CARCINOGEN-induced COLON CANCER. Mice, Inbred ICRC,Mice, ICR,Mouse, ICR,Mouse, Inbred ICR,Mouse, Inbred ICRC,ICR Mice,ICR Mice, Inbred,ICR Mouse,ICR Mouse, Inbred,ICRC Mice, Inbred,ICRC Mouse, Inbred,Inbred ICR Mice,Inbred ICR Mouse,Inbred ICRC Mice,Inbred ICRC Mouse
D010323 Passive Cutaneous Anaphylaxis An evanescent cutaneous reaction occurring when antibody is injected into a local area on the skin and antigen is subsequently injected intravenously along with a dye. The dye makes the rapidly occurring capillary dilatation and increased vascular permeability readily visible by leakage into the reaction site. PCA is a sensitive reaction for detecting very small quantities of antibodies and is also a method for studying the mechanisms of immediate hypersensitivity. Anaphylaxis, Passive Cutaneous,PCA,Cutaneous Anaphylaxis, Passive
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004423 Ear The hearing and equilibrium system of the body. It consists of three parts: the EXTERNAL EAR, the MIDDLE EAR, and the INNER EAR. Sound waves are transmitted through this organ where vibration is transduced to nerve signals that pass through the ACOUSTIC NERVE to the CENTRAL NERVOUS SYSTEM. The inner ear also contains the vestibular organ that maintains equilibrium by transducing signals to the VESTIBULAR NERVE. Vestibulocochlear System,Vestibulocochlear Apparatus,Apparatus, Vestibulocochlear,Ears,System, Vestibulocochlear
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006634 Histamine H1 Antagonists Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. Antihistamines, Classical,Antihistaminics, Classical,Antihistaminics, H1,Histamine H1 Antagonist,Histamine H1 Receptor Antagonist,Histamine H1 Receptor Antagonists,Histamine H1 Receptor Blockaders,Antagonists, Histamine H1,Antagonists, Histamine H1 Receptor,Antihistamines, Sedating,Blockaders, Histamine H1 Receptor,First Generation H1 Antagonists,H1 Receptor Blockaders,Histamine H1 Blockers,Receptor Blockaders, H1,Antagonist, Histamine H1,Classical Antihistamines,Classical Antihistaminics,H1 Antagonist, Histamine,H1 Antagonists, Histamine,H1 Antihistaminics,Sedating Antihistamines
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

N Sugiyama, and F Akahoshi, and S Kuwahara, and M Kajii, and Y Sakaue, and H Yakumaru, and M Sugiura, and C Fukaya
August 1964, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
N Sugiyama, and F Akahoshi, and S Kuwahara, and M Kajii, and Y Sakaue, and H Yakumaru, and M Sugiura, and C Fukaya
December 1997, Bioorganic & medicinal chemistry,
N Sugiyama, and F Akahoshi, and S Kuwahara, and M Kajii, and Y Sakaue, and H Yakumaru, and M Sugiura, and C Fukaya
June 1968, Biochemical pharmacology,
N Sugiyama, and F Akahoshi, and S Kuwahara, and M Kajii, and Y Sakaue, and H Yakumaru, and M Sugiura, and C Fukaya
June 1996, Chemical & pharmaceutical bulletin,
N Sugiyama, and F Akahoshi, and S Kuwahara, and M Kajii, and Y Sakaue, and H Yakumaru, and M Sugiura, and C Fukaya
May 2021, RSC advances,
N Sugiyama, and F Akahoshi, and S Kuwahara, and M Kajii, and Y Sakaue, and H Yakumaru, and M Sugiura, and C Fukaya
May 2002, Chemical & pharmaceutical bulletin,
N Sugiyama, and F Akahoshi, and S Kuwahara, and M Kajii, and Y Sakaue, and H Yakumaru, and M Sugiura, and C Fukaya
July 1998, Bioorganic & medicinal chemistry,
N Sugiyama, and F Akahoshi, and S Kuwahara, and M Kajii, and Y Sakaue, and H Yakumaru, and M Sugiura, and C Fukaya
April 2004, European journal of medicinal chemistry,
N Sugiyama, and F Akahoshi, and S Kuwahara, and M Kajii, and Y Sakaue, and H Yakumaru, and M Sugiura, and C Fukaya
April 1994, Farmaco (Societa chimica italiana : 1989),
N Sugiyama, and F Akahoshi, and S Kuwahara, and M Kajii, and Y Sakaue, and H Yakumaru, and M Sugiura, and C Fukaya
January 1991, Journal of medicinal chemistry,
Copied contents to your clipboard!